Polyamine Metabolism and Its Importance in Neoplastic Growth and as a Target for Chemotherapy

Cancer Research

Volumn 48, Issue 4, 1988, Pages 759-774

  Pegg, Anthony E ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER GROWTH; HUMAN; NONHUMAN; POLYAMINE METABOLISM; REVIEW;

ANIMAL; EFLORNITHINE; HUMAN; NEOPLASMS; ORNITHINE DECARBOXYLASE; POLYAMINES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023881236     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (172)

1. Williams-Ashman, H. G., and Canellakis, Z. N. Polyamines in mammalian biology and medicine. Perspect Biol. Med., 22:421-453, 1979.
2. Pegg, A. E., and McCann, P. P. Polyamine metabolism and function. Am. J. Physiol., 243: C212-C221,1982.
3. Tabor, C. W., and Tabor, H. Polyamines. Annu. Rev. Biochem., 53: 749-790,1984.
4. Pegg, A. E. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J., 234: 249–262, 1986.
5. Porter, C. W., and Sufrin, J. R. Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res., 6:525-542, 1986.
6. Janne, J., Holtta, E., Kallio, A., and Kapyaho, K. Role of polyamines and their antimetabolites in clinical medicine. Spec. Top. Endocrinol. Metabol., 5:227-293,1983.
7. McCann, P. P., Pegg, A. E., and Sjoerdsma, A. Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 1–371. Orlando, FL: Academic Press, 1987.
8. Tabor, C. W., and Tabor, H. Polyamines in microorganisms. Microbiol. Rev., 49:81-99, 1985.
9. Boutwell, R. K., O’Brien, T. G., Verma, A. K., Weekes, R. G., DeYoung, L. M., Ashendel, C. L., and Astrup, E. G. The induction of ornithine decarboxylase activity and its control in mouse skin epidermis. Adv. Enzyme Regul., 17:89-112, 1979.
10. Scalabrino, G., and Ferioli, M. E. Polyamines in mammalian tumors. Part 1. Adv. Cancer Res., 35:151-268, 1981; Part 2. Adv. Cancer Res., 36:1-102,1982.
11. Verma, A., and Boutwell, R. K. Inhibition of carcinogenesis by inhibitors of putrescine biosynthesis. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 249–258. Orlando, FL: Academic Press, 1987.
12. Marton, L. J., Edwards, M. S., Levin, V. A., Lubich, W. P., and Wilson, C. B. CSF polyamines: a new and important means of monitoring patients with medulloblastoma. Cancer (Phila.), 47:757-760,1981.
13. Hölttä, E., and Pohjanpelto, P. Polyamine dependence of Chinese hamster ovary cells in serum-free culture is due to deficient arginase activity. Biochim. Biophys. Acta, 727:321-327,1982.
14. Pegg, A. E. S-Adenosylmethionine decarboxylase: a brief review. Cell Biochem. Funct., 2:11-15,1984.
15. Pegg, A. E. The use of inhibitors to study the biochemistry and molecular biology of polyamine biosynthesis and uptake In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 107–119. Orlando, FL: Academic Press, 1987.
16. Katz, A., and Kahana, C. Transcriptional activation of mammalian ornithine decarboxylase during stimulated growth. Mol. Cell Biol. 7: 2641–2643, 1987.
17. Persson, L., Holm, I., and Heby, O. Translational regulation of ornithine decarboxylase by polyamines. FEBS Lett., 205:175-178, 1986.
18. Hölttä, E., and Pohjanpelto, P. Control of ornithine decarboxylase in Chinese hamster ovary cells by polyamines. J. Biol. Chem., 261: 9502- 9508.1986.
19. Kameji, T., and Pegg, A. E. Inhibition of translation of mRNAs for ornithine decarboxylase and S-adenosylmethionine decarboxylase by polyamines. J. Biol. Chem., 262:2427-2430,1987.
20. Rogers, S., Wells, R., and Rechsteiner, M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (Wash. DC), 234:364-368, 1986.
21. Heller, J. S., and Canellakis, E. S. Cellular control of ornithine decarboxylase activity by its antizyme. J. Cell. Physiol., 107:209-217, 1981.
22. Murakami, Y., and Hayashi, S. Role of antizyme in degradation of ornithine decarboxylase in HTC cells. Biochem. J., 226:893-896, 1985.
23. Russell, D. H. Ornithine decarboxylase may be a multifunctional protein. Adv. Enzyme Regul., 21:201-222,1983.
24. Meggio, F., Flamigni, F., Guarnieri, C., and Pinna, L. A. Location of the phosphorylation site for casein kinase-2 within the amino acid sequence of ornithine decarboxylase. Biochim. Biophys. Acta, 929: 114–116, 1987.
25. Shirahata, A., and Pegg, A. E. Increased content of mRNA for a precursor of S-adenosylmethionine decarboxylase in rat prostate after treatment with 2-difluoromethylomithine. J. Biol. Chem., 261:13833-13837,1986.
26. Mach, M., White, M. W., Neubauer, M., Degen, J. L., and Morris, D. R. Isolation of a cDNA clone encoding S-adenosylmethionine decarboxylase. J. Biol. Chem., 261: 11697-11703,1986.
27. Pegg, A. E., Kameji, T., Shirahata, A., Stanley, B., Madhubala, R., and Pajunen, A. Regulation of mammalian S-adenosylmethionine decarboxylase. Adv. Enzyme Regul., in press, 1988.
28. Shirahata, A., and Pegg, A. E. Regulation of S-adenosylmethionine decarboxylase activity in rat liver and prostate. J. Biol. Chem., 260:9583-9588, 1985.
29. Kameji, T., and Pegg, A. E. Effect of putrescine on the synthesis of S- adenosylmethionine decarboxylase. Biochem. J., 243:285-288, 1987.
30. Pegg, A. E., Wechter, R., and Pajunen, A. Increase in S-adenosylmethionine decarboxylase in SV-3T3 cells treated with S-methyl-5'-methylthioadenosine. Biochem. J., 244:49-54, 1987.
31. Erwin, B. G., and Pegg, A. E. Regulation of spermidine/spermine N1-acetyltransferase in L6 cells by polyamines and related compounds. Biochem. J., 238:581-587, 1986.
32. Pegg, A. E., Erwin, B. G., and Persson, L. Induction of spermidine/spermine N1-acetyltransferase by methylglyoxal bis(guanylhydrazone). Biochim. Biophys. Acta, 842:111-118,1985.
33. Williams-Ashman, H. G., and Seidenfeld, J. Aspects of the biochemical pharmacology of methylglyoxal bis(guanylhydrazone). Biochem. Pharmacol., 35:1217-1225, 1986.
34. Pegg, A. E., and Williams-Ashman, H. G. Pharmacologic interference with enzymes of polyamine biosynthesis and of 5’-methylthioadenosine metabolism. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 33–48. Orlando, FL: Academic Press, 1987.
35. Bey, P., Danzin, C., and Jung, M. Inhibition of basic amino acid decarboxylases involved in polyamine biosynthesis. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 1-32. Orlando, FL: Academic Press, 1987.
36. Pegg, A. E. Inhibitors of ornithine and S-adenosylmethionine decarboxylases. In: U. Bachrach, and Y. M. Heimer (eds.), The Physiology of Polyamines. Boca Raton, FL. CRC Press, in press, 1988.
37. Metcalf, B. W., Bey, P., Danzin, C., Jung, M. J., Casara, P., and Vevert, J. P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E. C. 4.1.1.17.) by substrate and product analogues. J. Am. Chem. Soc., 100:2551-2553,1978.
38. Sjoerdsma, A., and Schechter, P. J. Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin. Pharmacol. Ther., 35: 287–300, 1984.
39. Pegg, A. E., McGovern, K. A., and Wiest, L. Decarboxylation of α-difluoromethylomithine by ornithine decarboxylase. Biochem. J., 241:305-307, 1987.
40. Danzin, C., and Mamont, P. S. Polyamine inhibition in vivo and in organ growth and repair. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 141–164. Orlando, FI: Academic Press, 1987.
41. Sunkara, P. S., Baylin, S. B., and Luk, G. D. Inhibitors of polyamine biosynthesis: cellular and in vivo effects on tumor proliferation. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 121–140. Orlando, FL: Academic Press, 1987.
42. Pera, P. J., Kramer, D. L., Sufrin, J. R., and Porter, C. W. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res., 46:1148-1154.1986.
43. Mamont, P. S., Siat, M., Joder-Ohlenbusch, A.-M., Bernhardt, A., and Casara, P. Effect of (2R,5R)-6-heptyne-2,5-diamine, a potent inhibitor of L-ornithine decarboxylase, on rat hepatoma cells cultured in vitro. Eur. J. Biochem., 142:457-463,1984.
44. Pegg, A. E., Wechter, R. S., Clark, R. S., Wiest, L., and Erwin, B. G. Acetylation of decarboxylated S-adenosylmethionine by mammalian cells. Biochemistry, 25:379-384,1986.
45. Haegele, K. D., Splinter, T. A. W., Romjin, J. C., Schechter, P. J., and Sjoerdsma, A. Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by α-difluoromethylomithine. Cancer Res., 47:890-895,1987.
46. Heby, O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation, 19:1-20, 1981.
47. Fozard, J. R., and Koch-Weser, L. Pharmacological consequences of inhibition of polyamine biosynthesis with DL-α-difluoromethylornithine. Trends Pharmacol. Sci., 3:107-110, 1982.
48. Heby, O., Luk, G. D., and Schindler, J. Polyamine synthesis inhibitors act as both inducers and suppressors of cell differentiation. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 165–186, Orlando, FL: Academic Press, 1987.
49. Fozard, J. R. The contragestational effects of ornithine decarboxylase inhibition. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 187–202. Orlando, FL: Academic Press, 1987.
50. Luk, G. D., Goodwin, G., Marton, L. J., and Baylin, S. B. Polyamines are needed for the survival of human small-cell lung carcinoma in culture. Proc. Natl. Acad. Sci., USA, 78:2355-2358,1981.
51. Sunkara, P. S., Prakash, N. J., Chang, C. C., and Sjoerdsma, A. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with α-difluoromethylornithine against HeLa cells and mouse L1210 leukemia. J. Natl. Cancer Inst., 70:505-509,1983.
52. Sano, Y., Deen, D. F., Oredsson, S. M., and Marton, L. J. Effects of α-difluoromethyloniithine on the growth of 9L rat brain tumor multicellular spheroids and their response to l,3-bis(2-chloroethyl)-l-nitrosourea. Cancer Res., 44:577-581,1984.
53. Luk, G. D. and Baylin, S. B. Anchorage dependency effects of difluoromethylornithine cytotoxicity in human lung carcinoma cells. Cancer Res., 46:1844-1848,1986.
54. Luk, G. D., Abeloff, M. D., McCann, P. P., Sjoerdsma, A., and Baylin, S. B. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine. Cancer Res., 46:1849-1853,1986.
55. Tutton, P. J. M., and Barkla, D. H. Comparison of the effects of an ornithine decarboxylase inhibitor on the intestinal epithelium and on intestinal tumors. Cancer Res., 46: 6091-6094,1986.
56. Fujimoto, S., Igarashi, K., Shrestha, R. D., Miyazaki, M., and Okui, K. Antitumor effects of two polyamine antimetabolites combined with mitomycin C on human stomach cancer cells xenotransplanted into nude mice. Int J. Cancer, 35:821-825,1985.
57. Sunkara, P. S., and Rosenberger, A. L. Antimetastatic activity of DL-α-difluoromethylornithine, an inhibitor of polyamine biosynthesis in mice. Cancer Res., 47:933-935,1987.
58. Kubota, S., Ohsawa, N., and Takaku, F. Effects of DL-α-difluoromethylornithine on the growth and metastasis of B16 melanoma in viv o. Int J. Cancer, 39:244-247,1987.
59. Schechter, P. J., Barlow, J. L. R, and Sjoerdsma, A. Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 345–364. Orlando, FL: Academic Press, 1987.
60. Abeloff, M. D., Rosen, S. T., Luk, G. D., Baylin, S. B., Zeltzman, M., and Sjoerdsma, A. Phase II trials oa α-difluoromethylornithine, an inhibitor of polyamine synthesis in advanced small cell lung cancer and colon cancer. Cancer Treat Rep., 70; 843-845,1986.
61. Levin, V. A., Chamberlain, M. C., Prados, M. D., Choucair, A. K., Berger, M. S., Silver, P., Seager, M., Gutin, P. H., Davis, R. L., and Wilson, C. B. Phase I—II study of eflornithine and mitoguazone combined in the treatment of recurrent brain tumors. Cancer Treat Rep., 71:459-464,1987.
62. Talpaz, M., Plager, J., Quesda, R., Benjamin, H., Kantaijian, H., and Gutterman, J. Difluoromethylornithine and leukocyte interferon: a phase I clinical study in cancer patients. Eur. J. Cancer Clin. Oncol., 22:685-689, 1986.
63. Gilman, T. M., Paulson, Y. J., Boylen, C. T., Heseltine, P. N. R., and Sharma, O. P. Eflornithine treatment of Pneumocystis carinii pneumonia in AIDS. JAMA, 256: 2197-2198,1986.
64. Potyanpelto, P., Hölttä, E., and Jänne, O. A. Mutant strain of Chinese hamster ovary cells with no detectable ornithine decarboxylase activity. Mol. Cell. BioL, 5:1385-1390,1985.
65. Pohjanpelto, P., and Knuutila, S. Polyamine deprivation causes major chromosome aberrations in a polyamine-dependent Chinese hamster ovary cell line. Exp. Cell Res., 141:333-339,1982.
66. Knuutila, S., and Pohjanpelto, P. Polyamine starvation causes parallel increase in nuclear and chromosome aberrations in a polyamine-dependent strain of CHO. Exp. Cell Res., 143:222-226,1982.
67. Steglich, C., and Schefller, I. E. An ornithine decarboxylase-deficient mutant of Chinese hamster ovary cells. J. Biol. Chem., 257:4603-4609,1982.
68. Mamont, P. S., Danzin, C., Kolb, M., Gerhart, F., Bey, P., and Sjoerdsma, A. Marked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl)dehydroornithine. Biochem. Pharmacol., 35:159-165,1986.
69. Gerner, E. W., and Mamont, P. S. Restoration of the polyamine contents in rat hepatoma tissue-culture cells after inhibition of polyamine biosynthesis. Eur. J. Biochem., 156:31-35,1986.
70. Bartholeyns, J., Mamont, P., and Casara, P. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of L-ornithine decarboxylase in rodents. Cancer Res., 44:4972-4977.1985.
71. Williams, Ashman, H. G., and Schenone, A. Methylglyoxal bis-(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases. Biochem. Biophys. Res. Commun., 46:288-295,1972.
72. Porter, C. W., and Jänne, J. Modulation of antineoplastic drug action by inhibitors of polyamine biosynthesis. 1n P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 203–248. Orlando, FL: Academic Press, 1987.
73. Jänne, J., Alhonen-Hongisto, L., Nikula, P., and Elo, H. 5-Adenosylmethionine decarboxylase as a target of chemotherapy. Adv. Enzyme Regul., 24:125-139,1985.
74. Janne, J., and Morris, D. R. Inhibition of S-adenosylmethionine decarboxylase and diamine oxidase activities by analogues of methylglyoxal bis(guanylhydrazone) and their cellular uptake during lymphocyte activation. Biochem. J., 218:947-951,1984.
75. Kallio, A., and Jänne, J. Role of diamine oxidase during the treatment of tumor-bearing mice with combinations of polyamine anti-metabolites. Biochem. J., 212:895-898,1983.
76. Artamonova, E. Y., Zavalova, L. L., Khomutov, R. M., and Khomutov, A. R. Irreversible inhibition of S-adenosylmethionine decarboxylase by hy-droxylamine-containing analogues of decarboxylated S-adenosylmethionine. Bioorg. Khim., 12:206-212,1986.
77. Secrist, J. A., III. New substrate analogues as inhibitors of S-adenosyl-methionine decarboxylase. Nucleosides & Nucleotides, 6:73-84, 1987.
78. Pegg, A. E., Jones, D. B., and Secrist, J. A., III. Effect of inhibitors of S-adenosylmethionine decarboxylase on polyamine content and growth of L1210 cells. Biochemistry, in press, 1988.
79. Coward, J. K., and Pegg, A. E., Specific multisubstrate adduct inhibitors of aminopropyltransferases and their effect on polyamine biosynthesis in cultured cells. Adv. Enzyme Regul., 26: 107-113,1987.
80. Pegg, A. E., Tang, K.-C., and Coward, J. K. Effect of S-adenosy 1-1,8-diamino-3-thiooctane on polyamine metabolism. Biochemistry, 21: 5082-5089,1982.
81. Pegg, A. E., and Coward, J. K. Growth of mammalian cells in the absence of the accumulation of spermine. Biochem. Biophys. Res. Commun., 133: 82-89,1985.
82. Pegg, A. E., Coward, J. K., Talekar, R. R., and Secrist, J. A. III. Effect of certain 5’-substituted adenosine on polyamine synthesis: selective inhibitors of spermine synthase. Biochemistry, 25:4091-4097,1986.
83. Hamaguchi, K., Iwakari, T., Imamura, K., Furihata, K., Seto, H., and Otake, N. Juglorin, a new spermidine synthase inhibitor. J. Antibiot. (Tokyo) Ser. A, 40:717-719,1987.
84. Ito, H., Hibasami, H., Keshiro, S., Nagai, J., and Hidaka, H. Antitumor effect of dkyriohexylammonium sulfate, a potent inhibitor of spermidine synthase, against P388 leukemia. Cancer Lett, 15:229-235,1982.
85. Feuerstein, B. G., Deen, D. F., and Marton, L. J. Effects of dkydohexylamine sulfate, a spermidine synthase inhibitor, in 9L rat brain tumor cells. Cancer Res., 45:4950-4954,1985.
86. Mitchell, J. L. A., Mahan, D. W., McCann, P. P., and Qasba, P. Dicyclo-hexylamine effects on HTC polyamine content and ornithine decarboxylase activity. Biochim. Biophys. Acta, 840:309-316,1985.
87. Nakashima, K., Tsukada, T., Hibasami, H., and Maekawa, S. Synthesis of N-chlorosulfonyl dicydohexylamine as a potent inhibitor for spermidine synthase and its effects on human leukemia Molt 4B cells. Biochem. Biophys. Res. Commun., 141:718-722, 1986.
88. Alhonen-Hongisto, L., Sëppanen, P., and Janne, J. Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis(guanylhydrazone). Biochem. J., 192: 941-945,1980.
89. Mandel, J.-L., and Flintoff, W. F. Isolation of mutant mammalian cells altered in polyamine transport. J. Cell. Physiol., 97:335-344,1978.
90. Rinehart, C. A., and Chen, K. Y. Characterization of the polyamine transport system in mouse neuroblastoma cells. Effects of sodium and system A amino acids. J. Biol. Chem., 259:4750-4756,1984.
91. Byers, T. L., Kameji, R., Rannels, D. E., and Pegg, A. E. Multiple pathways for uptake of paraquat, methylglyoxal bis(guanylhydrazone), and polyamines. Am. J. Physiol., 252: C663-C669,1987.
92. Porter, C. W., Bergeron, R. J., and Stolowich, N. J. Biological properties of N4-spermidine derivatives and their potential in anticancer chemotherapy. Cancer Res., 42:4072-4078,1982.
93. Kallio, A., Seppanen, P., Alhonen-Hongisto, L., and Janne, J. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration. Cancer Res., 43: 324-327,1983.
94. Kramer, D. L., Paul, B., and Porter, C. Effect of pretreatment with α-difluoromethylornithine on the selectivity of methylglyoxal bis-(guanylhydrazone) for tumor tissue in L1210 leukemic mice. Cancer Res., 45:2512-2515.1985.
95. Wiseman, A., Kramer, D. L., and Porter, C. W. Isolation and uptake characteristics of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone). Cancer Res., 43: 5937-5942,1983.
96. Madhubala, R., Secrist, J. A., III, and Pegg, A. E. Properties of L1210 cells resistant to α-difluoromethylornithine. Fed. Proc., 46:2254 (1987).
97. Porter, C. W., Cavanaugh, P. F., Stolowich, N., Ganis, B., Kelley, E., and Bergeron, R. J. Biological properties of N4- and N1,N4-spermidine derivatives in cultured L1210 leukemia cells. Cancer Res., 45:2050-2057,1985.
98. Heston, W. D. W., Yang, C.-R., Pliner, L., Russo, P., and Covey, D. F. Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line. Cancer Res., 47: 3627-3631,1987.
99. Casero, R. A., Bergeron, R. J., and Porter, C. W. Treatment with α-difluoromethylomithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells. J. Cell. Physiol., 727:476-482,1984.
100. McGovern, K. A., Clark, R. S., and Pegg, A. E. Effect of 1,3,6-triamino-hexane and 1,4,7-triaminoheptane on growth and polyamine metabolism in SV-3T3 cells treated with 2-difluoromethylornithine. J. Cell. Physiol., 127: 311-316,1986.
101. Mamont, P. S., Danzin, C., Wagner, J., Siat, M., Joder-Ohlenbusch, A.-M., and Claverie, N. Accumulation of decarboxylated S-adenosylmethion-ine in mammalian cells as a consequence of the inhibition of putrescine synthesis. Eur. J. Biochem., 123:499-504, 1982.
102. Porter, C. W., Ganis, B., Vinson, T., Marton, L. J., Kramer, D. L., and Bergeron, R. J. Comparison and characterization of growth inhibition by a-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N4-bis(ethyl)spennidine, an apparent regulator of the enzyme. Cancer Res., 46:6279-6285, 1986.
103. Porter, C. W., McManis, J., Casero, R. A., and Bergeron, R. J. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine and spermine to regulate polyamine biosynthesis and inhibit cell growth. Cancer Res., 47: 2821–2825, 1987.
104. Porter, C. W., Berger, F. G., Pegg, A. E., Ganis, B., and Bergeron, R. J. Regulation of ornithine decarboxylase activity by spermidine and the spermidine analog, N1,N4-bis(ethyl)spermidine. Biochem. J., 242: 433–440, 1987.
105. Casero, R., Go, B., Theiss, H. W., Smith, J., Baylin, S. B., and Luk, G. D. Cytotoxic response of the relatively difluoromethylomithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue, bis(ethyl)spermidine. Cancer Res., 47:3964-3967,1987.
106. Prakash, N. J., Schechter, P. J., Mamont, P. S., Grove, J., Koch-Weser, J., and Sjoerdsma, A. Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis: effects of a-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Life Sci., 26:181-194,1980.
107. Bartholeyns, J., and Koch-Weser, J. Effect of α-difluoromethylornithine alone and combined with Adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice and solid tumors induced by injection of hepatoma tissue culture cells in rats. Cancer Res., 41:5158-5161,1981.
108. Kallio, A., Nikula, P., and Janne, J. Transfer of intestine-derived diamines into tumor cells during treatment of Ehrlich ascites carcinoma-bearing mice with polyamine anti-metabolites. Biochem. J., 218:641-644,1984.
109. Marton, L. J., Levin, V. A., Hervatin, S. J., Koch-Weser, J., McCann, P. P., and Sjoerdsma, A. Potentiation of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by α-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res., 41:4426-4431,1981.
110. Marton, L. J. Polyamines and Cancer Therapy. In: D. F. Tierney (Moderator), Polyamines in Clinical Disorders. West. J. Med., 142:63-73, 1985.
111. Marton, L. J. Effects of treatment with DNA-directed cancer chemotherapeutic agents after polyamine depletion. Pharmacol. Ther., 32: 183–190, 1987.
112. Seidenfeld, J., and Komar, K. A. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylomithine-induced polyamine depletion. Cancer Res., 45: 2132–2138, 1985.
113. Ducore, J. M., and McNamara, L. Effect of a-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand crosslinking in a human cell line in vitro. Cancer Res., 46:1068-1072,1986.
114. Tofilon, P. J., Deen, D. F., and Marton, L. J. α-Difluoromethylomithine-induced polyamine depletion of 9L tumor cells modifies drug-induced DNA cross-link formation. Science (Wash. DC), 222; 1132-1134,1983.
115. Seidenfeld, J., Barnes, D., Block, A., and Erickson, L. C. Comparison of DNA interstrand cross-linking by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine depleted and control human adenocarcinoma cells. Cancer Res., 47:4538-4543, 1987.
116. Chang, B. K., Black, O., and Gutman, R. Inhibition of growth of human or hamster pancreatic cancer cell lines by α-difluoromethylornithine alone or combined with cis-diamminedichloroplatinum(II). Cancer Res., 44: 5100-5104,1984.
117. Allen, E. D., and Natale, R. B. Effect of a-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminedichlo-roplatinum(II), and vinblastine sulfate on the growth of P3J cells in vitro. Cancer Res., 46:3550-3555,1986.
118. Seidenfeld, J., Komar, K. A., Naujokas, M. F., and Block, A. L. Effects of DFMO-induced polyamine depletion on human tumor cell sensitivity to antineoplastic DNA-crosslinking drugs. Cancer Chemother. Pharmacol., 77; 16–20, 1986.
119. Seidenfeld, J., Block, A. L., Komar, K. A., and Naujokas, M. F. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine. Cancer Res., 46:47-53, 1986.
120. Seidenfeld, J., Komar, K. A., Naujokas, M. F., and Block, A. L. Reduced cytocidal efficacy for Adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment. Cancer Res., 46: 1155–1159, 1986.
121. Luk, G. D., Marton, L. J., and Baylin, S. B. Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science (Wash. DC), 210:195-198,1980.
122. Sunkara, P. S., Prakash, N. J., Mayer, G. D., and Sjoerdsma, A. Tumor suppression with a combination of α-difluoromethylornithine and interferon. Science (Wash. DC), 219:851-853,1983.
123. Gohji, K., Murao, S.-I., Maeda, S., Sugiyama, T., and Kamidono, S. Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of α-difluoromethylornithine and recombinant 7-interferon. Cancer Res., 46:6264-6268,1986.
124. Bepler, G., Carney, D. N., Nau, M. M., Gazdar, A. F., and Minna, J. D. Additive and differential activity of a-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Cancer Res., 46: 3413–3419, 1986.
125. Prakash, N. J., Sunkara, P. S., and Sjoerdsma, A. Potentiation by o-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a ty-rosinase-dependent melanolytic agent, against B16 melanoma. Biochem. Pharmacol., 34:1887-1890,1985.
126. Saydjari, R., Townsend, C. M., Barranco, S. C., James, E., and Thompson, J. C. Effects of cyclosporin A and α-difluoromethylornithine on the growth of hamster pancreatic cancer in vitro. J. Natl. Cancer Inst., 77; 1087–1092, 1986.
127. Fuller, D. J. M., and Gerner, E. W. Delayed sensitization to heat by inhibitors of polyamine-biosynthetic enzymes. Cancer Res., 42:5046-5049, 1982.
128. Fuller, D. J. M., and Gerner, E. W. Sensitization of Chinese hamster ovary cell to heat shock by α-difluoromethylornithine. Cancer Res., 47:816-820, 1987.
129. Mivechi, N. F., Dewey, W. C., Feuerstein, B. G., Deen, D. F., and Marton, L. J. Relationship between heat sensitivity and polyamine levels after treatment with α-difluoromethylornithine (DFMO). Radiat. Res. 108:269-281, 1986.
130. McConlogue, L., and Coffino, P. A mouse lymphoma cell mutant whose major protein product is ornithine decarboxylase. J. Biol. Chem., 258: 12083-12086,1983.
131. Kahana, C., and Nathans, D. Isolation of cloned cDNA encoding mammalian ornithine decarboxylase. Proc. Natl. Acad. Sci. USA, 81: 3645–3649, 1984.
132. Leinonen, P., Alhonen-Hongisto, L., Laine, R., Janne, O. A., and Janne, J. Human myeloma cells acquire resistance to difluoromethylornithine by amplification of the ornithine decarboxylase gene. Biochem. J., 242: 199-203.1987.
133. McConlogue, L., Dana, S. L., and Coffino, P. Multiple mechanisms are responsible for altered expression of ornithine decarboxylase in overproducing variant cells. Mol. Cell. Biol., 6: 2865-2871,1986.
134. Mamont, P. S., Duchesne, M.-C., Grove, J., and Tardif, C. Initial characterization of a HTC cell variant partially resistant to the anti-proliferative effect of ornithine decarboxylase inhibitors. Exp. Cell Res., 775; 387–393, 1978.
135. Pösö, H., Karvonen, E., Sumalainen, H., and Anderson, L. C. A human neuroblastoma cell line with an altered ornithine decarboxylase. J. Biol. Chem., 259:12307-12310,1984.
136. Alhonen-Hongisto, L., Leinonen, P., Laine, R., and Janne, J. Human myeloma cells acquire resistance to difluoromethylornithine without overproducing ornithine decarboxylase. Biochem. Biophys. Res. Commun., 144: 732–737, 1987.
137. putrescine 137. Medrano, E. E., Burrone, O. R., Ferrer, M. M., Cafferata, E. G. A., and Algranati, I. D. A novel mechanism of resistance to α-difluoromethylomithine induced by cycloheximide. Growth with abnormally low levels of and spermidine. FEBS Lett., 206:106-110,1986.
138. Williams-Ashman, H. G., Seidenfeld, J., and Galletti, P. Trends in the biochemical pharmacology of 5'-deoxy-5'-methylthioadenosine. Biochem. Pharmacol., 35:1217-1225,1982.
139. Schlenk, F. Methylthioadenosine. Adv. Enzymol., 54:195-266, 1983.
140. Kamatani, N., Yu, A. L., and Carson, D. A. Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo. Blood, 60: 1387–1391, 1982.
141. Kubota, M., Kajender, E. O., and Carson, D. A. Independent regulation of ornithine decarboxylase and 5-adenosylmethionine decarboxylase in methylthioadenosine phosphorylase-deficient malignant murine lymphoblasts. Cancer Res., 45: 3567–3572, 1985.
142. Stoeckler, J. D., and Li, S. Influx of 5'-deoxy-5’-methylthioadenosine into HL-60 human leukemia cells and erthrocytes. J. Biol. Chem., 262: 9542-9546.1987.
143. Della Ragione, F., and Pegg, A. E. Effect of analogues of 5’-methylthioadenosine on cellular metabolism. Biochem. J., 210:429-435, 1983.
144. White, M. W., Riscoe, M. K., and Ferro, A. J. The comparative effects of 5’-methylthioadenosine and some of its analogs on cells containing, and deficient in, 5’-methylthioadenosine phosphorylase. Biochim. Biophys. Acta, 762:405-414,1983.
145. Yamanaka, H., Kubota, M., and Carson, D. A. Synergistic inhibition of polyamine biosynthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cell. Cancer Res., 47:1771-1774,1987.
146. Carteni-Farina, M., Cacciapuoti, G., Porcelli, M., Della Ragione, F., Lan-cieri, M., Geraci, G., and Zappia, V. Studies of the metabolic effects of methylthioformycin. Biochim. Biophys. Acta, 805: 158-164,1984.
147. Pankaskie, M. C., and Lakin, D. D. Analogs of 9-deazaadenosine: potent inhibitors of methylthioadenosine phosphorylase. Biochem. Pharmacol., 36:2063-2064, 1987.
148. Savarese, T. M., Ghoda, L. Y., and Parks, R. E. Biochemical considerations in the design of analogs of 5'-deoxy-5’-methylthioadenosine. In: Y.-C. Cheng, B. Goz, and M. Minkoff (eds.), Development of Target Oriented Anticancer Drugs, pp. 129–142. New York: Raven Press, 1983.
149. Savarese, T. M., Cannistra, A. J., Parks, R. E., Secrist, J. A., Shortnacy, A. T., and Montgomery, J. A. 5'-Deoxy-5'-methylthioadenosine phosphorylase-IV. Biological activity of 2-fluoroadenine-substituted 5'-deoxy-5’-methylthioadenosine analogs. Biochem. Pharmacol., 36:1881-1893,1987.
150. Kamatani, N., Nelson-Rees, W. A., and Carson, D. A. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine deficient metabolic enzyme. Proc. Natl. Acad. Sci. USA, 78:1219-1223,1981.
151. Ghoda, L. Y., Savarese, T. M., Dexter, D. L., Parks, R. E., Trackman, P. C., and Abeles, R. H. Characterization of a defect in the pathway for converting 5'-deoxy-5’-methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma. J. Biol. Chem., 259: 6715-6719,1984.
152. Paulus, T. J., Cramer, C. L., and Davis, R. H. Compartmentation of polyamines in Newrospora crassa. J. Biol. Chem., 258:8608-8612,1983.
153. Davis, R. H., Krasner, G. N., Digagni, J. J., and Ristow, J. L. Distinct roles of putrescine and spermidine in the regulation of ornithine decarboxylase in Neurospora crassa. Proc. Natl. Acad. Sci. USA, 82:4105-4109, 1985.
154. Toninello, A., Di Lisa F., Siliprandi, D., and Siliprandi, N. Uptake of spermine by rat liver mitochondria and its influence on the transport of phosphate. Biochim. Biophys. Acta, 815:399-404,1985.
155. Hougard, D. M., Nielsen, J. H., and Larsson, L.-I. Localization and biosynthesis of polyamines in insulin-producing cells. Biochem. J., 238:43-47,1986.
156. Moore, M. A., Tsuda, H., Ogiso, T., Mera, Y., and Ito, N. Enhancement of phenotypic instability by α-difluoromethylornithine and butylated hy-droxyanisole in rapidly induced rat liver lesions. Cancer Lett., 25:145-151, 1982.
157. Nakadate, T., Aizu, E., Yamamoto, S., Fujiki, H., Sugimura, T., and Kato, R. Inhibition of teleocidin-caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase-inhibitors. Jpn. J. Pharmacol., 37:253-258,1985.
158. Homma, Y., Ozono, S., Numata, I., Seidenfeld, J., and Oyasu, R. α-Difluoromethylornithine inhibits cell growth stimulated by a tumor-promoting rat urinary fraction. Carcinogenesis (Lond.), 6:159-161,1985. 159. Malt, R. A., Kingsnorth, A. N., Lamuraglia, G. M., Lacaine, F., and Ross, J. S. Chemoprevention and chemotherapy by inhibition of ornithine decarboxylase activity and polyamine synthesis: colonic, pancreatic, mammary and renal carcinomas. Adv. Enzyme Regul., 24:93-102, 1985. 160. Klinken, S. P., Castilla, M. J., and Thorgiersson, S. S. Effect of inhibitors of ornithine decarboxylase on retrovirus induced transformation of murine erythroid precursors in vitro. Cancer Res., 46:6246-6249,1986.
159. Thompson, H. J., Herbst, E. J., and Meeker, L. D. Chemoprevention of mammary carcinogenesis: a comparative review of the efficacy of a polyamine antimetabolite, retinoids and selenium. J. Natl. Cancer Inst., 77:595-598.1986.
160. Thompson, H. J., and Ronan, A. M. Effect of D.L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis (Lond.), 7; 2003-2006,1986.
161. Kingsnorth, A. N., King, W. W. K., Diekema, K. A., McCann, P. P., Ross, J. S., and Malt, R. A. Inhibition of ornithine decarboxylase with 2-difluo-romethyloraithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res., 43:2545-2549,1983.
162. Nigo, N. D., Bull, A. W., and Boyd, M. E. Importance of the duration of inhibition of intestinal carcinogenesis by difluoromethylornithine in rats. Cancer Lett., 35:153-158, 1987.
163. Nigro, N. D., Bull, A. W., and Boyd, M. E. Inhibition of intestinal carcinogenesis in rats. Effect of difluoromethylornithine with piroxicam or fish oil. J. Natl. Cancer Inst., 77; 1309-1313,1986.
164. Homma, Y., Ozono, S., Numata, I., Seidenfeld, J., and Oyasu, R. Inhibition of carcinogenesis by α-difluoromethylomithine in heterotopically transplanted rat urinary bladders. Cancer Res., 45:648-652, 1985.
165. Verma, A., Pong, R.-C., and Erickson, D. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 46:6149-6155,1986.
166. Gilmour, S. K., Verma, A. K., Madara, T., and O’Brien, T. G. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res., 47: 1221–1225, 1987.
167. O’Brien, T. G., Madara, T., Pyle, J. A., and Holmes, M. Ornithine decarboxylase from mouse epidermis and epidermal papillomas: difference in enzymatic properties and structure. Proc. Natl. Acad. Sci. USA, 83:9448-9452.1986.
168. O’Brien, T. G., Hietala, O., O’Donnell, K., and Holmes, M. Activation of mouse epidermal tumor ornithine decarboxylase by GTP: evidence for different catalytic forms of the enzyme. Proc. Natl. Acad. Sci. USA, 84: 8927-8931,1987.
169. Luk, G. D., and Baylin, S. B. Ornithine decarboxylase as a biological marker in familial colonic polyposis. N. Engl. J. Med., 311:80-83, 1984.
170. Porter, C., Herrera-Ornelas, L., Pera, P., Petrelli, N. F., and Mittleman, A. Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues. Cancer, 60: 1275-1281,1987.
171. Moorehead, R. J., Hoper, M., and McKelvay, S. T. D. Assessment of ornithine decarboxylase in rectal mucosa as a marker for colorectal adenomas and carcinomas. Br. J. Surg. 74: 364-365,1987.
172. Winqvist, R., Mäkelä, T. P., Seppänen, P., Janne, O. A., Alhonen-Hongisto, L., Janne, J., Grzeschik, K.-H., and Alitalo, K. Human ornithine decarboxylase sequences map to chromosome regions 2pter→p23 and 7cen→qter but are not coamplified with the NYMC oncogene. Cytogenet Cell Genet, 42:133-140,1986.